Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN – Get Free Report) was the target of a significant decline in short interest in June. As of June 15th, there was short interest totalling 19,100 shares, a decline of 28.5% from the May 31st total of 26,700 shares. Based on an average daily trading volume, of 179,400 shares, the days-to-cover ratio is currently 0.1 days.
Enzon Pharmaceuticals Stock Performance
Shares of OTCMKTS ENZN traded down $0.01 during trading on Monday, reaching $0.17. The stock had a trading volume of 11,828 shares, compared to its average volume of 29,452. Enzon Pharmaceuticals has a fifty-two week low of $0.06 and a fifty-two week high of $0.24. The business’s 50-day moving average price is $0.13 and its 200-day moving average price is $0.10. The company has a market cap of $12.62 million, a P/E ratio of 17.00 and a beta of 0.51.
About Enzon Pharmaceuticals
See Also
- Five stocks we like better than Enzon Pharmaceuticals
- Using the MarketBeat Stock Split Calculator
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- How to Invest in Insurance Companies: A Guide
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- How to Evaluate a Stock Before Buying
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Enzon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.